骨生物製劑市場：按產品、用途和最終用戶分類 - 全球預測 2023-2030

全球骨生物製品市場預計將大幅成長，2023年將達到196.4億美元，2030年將達到248億美元，年複合成長率為3.36%。

FPNV定位矩陣

FPNV定位矩陣對於評估全球骨生物製劑市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球骨生物製劑市場規模及預測為何？

2.在預測期內，COVID-19 對全球骨生物製劑市場的阻礙因素與影響為何？

3. 在預測期內，全球骨生物製品市場需要投資哪些產品/細分市場/應用/領域？

4.全球骨生物製劑市場的競爭策略為何？

5. 全球骨生物製劑市場的技術趨勢和法律規範是什麼？

6.全球骨生物製劑市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球骨生物製品市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 骨感染疾病、骨質疏鬆和骨壞死增加
    • 對人口高齡化加劇和與年齡相關的骨質疏鬆的擔憂
    • 接受骨生物材料帶來的好處
  • 抑制因素
    • 雙磷酸鹽的副作用
  • 機會
    • 脊椎融合手術手術數量增加
    • 骨生物製品領域的研究與開發
  • 任務
    • 缺乏知識和缺乏熟練的專業人員
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 生物製品市場：副產品

• 同種異體移植物
• 骨髓抽吸濃縮物
• 骨形成蛋白
• 去礦骨基質
• 富含血漿的蛋白質
• 合成骨科生物製劑
• 黏度供給產品

第7章 生物製品市場：依用途

• 骨折恢復
• 顎顏面和牙科用途
• 骨關節炎和骨關節炎
• 軟組織損傷
• 脊椎融合手術

第8章 生物製劑市場：依最終用戶分類

• 牙科診所和設施
• 醫院
• 研究和學術機構
• 專科診所

第9章 美洲骨生物製品市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太骨生物製品市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲骨生物製品市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Osteobiologics Market is forecasted to grow significantly, with a projected USD 19.64 billion in 2023 at a CAGR of 3.36% and expected to reach a staggering USD 24.80 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Osteobiologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Osteobiologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, and Visco-Supplementation Products. The Plasma-Rich Protein is projected to witness significant market share during forecast period.

Based on Application, market is studied across Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, and Spinal Fusion. The Maxillofacial & Dental Applications is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, and Specialty Clinics. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Osteobiologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Osteobiologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Osteobiologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Osteobiologics Market?

4. What is the competitive strategic window for opportunities in the Global Osteobiologics Market?

5. What are the technology trends and regulatory frameworks in the Global Osteobiologics Market?

6. What is the market share of the leading vendors in the Global Osteobiologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Osteobiologics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Osteobiologics Market, by Product, 2022 vs 2030
• 4.3. Osteobiologics Market, by Application, 2022 vs 2030
• 4.4. Osteobiologics Market, by End-User, 2022 vs 2030
• 4.5. Osteobiologics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of bone infections, osteoporosis, and osteonecrosis
    • 5.1.1.2. Growth in aging population and age related bone weakening concerns
    • 5.1.1.3. Acceptance over benefits offered by Osteobiologic substances
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse effects of bisphosphonates
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising number of spine fusion surgeries
    • 5.1.3.2. Research & Development in the arena of osteobiologics
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and dearth of skilled professionals
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Osteobiologics Market, by Product

• 6.1. Introduction
• 6.2. Allografts
• 6.3. Bone Marrow Aspirate Concentrate
• 6.4. Bone Morphogenic Protein
• 6.5. Demineralized Bone Matrices
• 6.6. Plasma-Rich Protein
• 6.7. Synthetic Orthobiologics
• 6.8. Visco-Supplementation Products

7. Osteobiologics Market, by Application

• 7.1. Introduction
• 7.2. Fracture Recovery
• 7.3. Maxillofacial & Dental Applications
• 7.4. Osteoarthritis & Degenerative Arthritis
• 7.5. Soft-Tissue Injuries
• 7.6. Spinal Fusion

8. Osteobiologics Market, by End-User

• 8.1. Introduction
• 8.2. Dental Clinics & Facilities
• 8.3. Hospitals
• 8.4. Research & Academic Institutes
• 8.5. Specialty Clinics

9. Americas Osteobiologics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Osteobiologics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Osteobiologics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. OSTEOBIOLOGICS MARKET RESEARCH PROCESS
• FIGURE 2. OSTEOBIOLOGICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. OSTEOBIOLOGICS MARKET DYNAMICS
• FIGURE 9. OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. OSTEOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. OSTEOBIOLOGICS MARKET SIZE, BY MAXILLOFACIAL & DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. OSTEOBIOLOGICS MARKET SIZE, BY OSTEOARTHRITIS & DEGENERATIVE ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. OSTEOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. OSTEOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS & FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. CHINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. ITALY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. POLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. QATAR OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 151. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 152. OSTEOBIOLOGICS MARKET LICENSE & PRICING